Researchers are set to launch a groundbreaking clinical trial evaluating the efficacy of smoked medical marijuana in treating post-traumatic stress disorder (PTSD) among military veterans. The U.S. Food and Drug Administration (FDA) Division of Psychiatry Products has cleared the Multidisciplinary Association for Psychedelic Studies (MAPS)’ Phase 2 study of smoked cannabis in Veterans for the … Continue reading FDA Approves Landmark Study on Smoked Marijuana for Treating PTSD in Veterans